| FIA | fistula in ano; fluorescent immunoassay; focal immunoassay; Freund incomplete adjuvant |
|---|---|
| IBBBB | incomplete bilateral bundle branch block |
| IFA | idiopathic fibrosing alveolitis; immunofluorescence assay; immunofluorescent antibody; incomplete Fr... |
| ILBBB | incomplete left bundle branch block |
| IMP | idiopathic myeloid proliferation; impression; incomplete male pseudohermaphroditism; individual Medi... |
| incomplete foot presentation | See: breech presentation. (05 Mar 2000) |
|---|---|
| incomplete fracture | A fracture in which the line of fracture does not include the entire bone. (05 Mar 2000) |
| incomplete hemianopia | Hemianopsia involving less than half the visual field of each eye. (05 Mar 2000) |
| incomplete metamorphosis | The development of a nymph into the imago which in many respects resembles the former; characteristic of more primitive insect orders, such as Heteroptera (true bugs), Orthoptera (locusts, grasshoppers), and Blatterria (roaches). Synonym: heterometabolous metamorphosis. (05 Mar 2000) |
| incomplete tetanus | Tetanus in which each stimulus causes a contraction to be initiated when the muscle has only partly relaxed from the previous contraction. (05 Mar 2000) |
| Freund's incomplete adjuvant | Water-in-oil emulsion of antigen, without mycobacteria. (05 Mar 2000) |
| acetone-insoluble antigen | A diphosphatidyl glycerol that is found in the membrane of Treponema pallidum and is the antigen detected by the Wasserman test for syphilis. (18 Nov 1997) |
| allogeneic antigen | Genetic variations of the same antigens within a given species. (05 Mar 2000) |
| antigen | Virus coded cell surface antigens that appear soon after the infection of a cell by virus, but before virus replication has begun. See: early gene. (18 Nov 1997) |
| antigen-antibody complex | The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes immune complex diseases. If the antigen is polyvalent the complex may be insoluble. Immune complexes activate complement through the classical pathway. See: glomerulonephritis, Arthus reaction, type III hypersensitivity. (12 Dec 1998) |
| antigen-antibody reaction | The phenomenon, occurring in vitro or in vivo, of antibody combining with antigen of the type that stimulated the formation of the antibody, thereby resulting in agglutination, precipitation, complement fixation, greater susceptibility to ingestion and destruction by phagocytes, or neutralization of exotoxin. See: skin test. (05 Mar 2000) |
| antigen-binding site | <immunology> In immune network theory, an idiotope, an antigenic site of an antibody that is responsible for that antibody binding to an antigenic determinant (epitope). Also used of the site on a ligand molecule to which a cell surface receptor binds. (18 Nov 1997) |
| antigen-combining site | See: paratope. (05 Mar 2000) |
| antigen excess | In a precipitation test, the presence of uncombined antigen above that required to combine with all of the antibody; precipitation may be inhibited because the presence of excess antigen gives rise to soluble antigen-antibody complexes, in vivo the resultant antigen-antibody interaction in such an antigen excess may give rise to immune complexes, which have a potential to induce cellular damage; such injury underlies the pathologic changes seen in certain immune complex diseases. (05 Mar 2000) |
| antigen interferon | <cytokine> Interferon elaborated by T lymphocytes in response to either specific antigen or mitogenic stimulation. This type II interferon can be produced by recombinant DNA technology and is similar to the interferon secreted by lymphocytes and has antiviral and antineoplastic activity. Synonym: antigen interferon, immune interferon. Pharmacological action: antineoplastic agent, antiviral agents. (20 Sep 2002) |